Ashutosh Chilkoti

Dr. Chilkoti’s research explores the interactions of biological and synthetic polymers with biology at the molecular level, with the goal of developing molecular tools and devices for medicine and biotechnology. Through a series of approximately 100 papers in the past two decades, his research group has pioneered the design and synthesis of genetically encoded stimulus-responsive elastin-like polypeptides and their fusions with peptides and proteins, with applications in protein purification and drug delivery. Dr. Chilkoti co-founded PhaseBio Pharmaceuticals in 2002 and served as a member of the company’s board of directors from 2002 to 2018.